Elnas, Emelda S.
HRN: 17-08-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/11/2023
05/18/2023
IV
500 MG
Prior OR
Cholelithiasis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes